Stockholm Convention Secretariat opens call for comments on draft review of PFOI→PFOB (pharmaceuticals) specific exemption

The Stockholm Convention Secretariat posted an invitation for Parties and stakeholders to submit comments on a draft report reviewing the specific exemption for use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for the purpose of producing pharmaceutical products. Compliance teams in affected supply chains (fluorochemicals and pharma intermediates) should review the draft review report and submit technical/economic information within the stated comment window, as outcomes can inform whether the exemption is continued, modified, or allowed to expire in future COP decisions.